Services Agreement for the production of fill finished vaccines for COVID-19 and therapeutics for use in the UK health system
Estimated value
£50.0m
Awarded value
£50.0m
Awarded 30 Jul 2020
Suppliers
1
Lots
1
1 awarded
Published
07 Oct 2020
Deadline 17 Jul 2020
Description
The reservation of fill & finish manufacturing capacity at C P Pharmaceutical's Wrexham site for 18 months, which will provide capacity for vaccine in bulk product form to be converted into individual doses capable of roll out via a mass vaccination programme.
Scope
- Reference
- 2526/07/2020
- Total value
- £50,000,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Jul 2020 to 01 Feb 2022
- CPV classifications
- 33600000
Submission & procedure
- Submission deadline
- 17 Jul 2020, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£50.0m
Award date
30 Jul 2020
Contract start
31 Jul 2020
Contract end
01 Feb 2022
Awarded to